Following the discovery of a novel virus subvariant known as JN.1, Karnataka reported two COVID-19-related deaths in the previous 24 hours amid an increase in infections. The two dead were men, 44 and 76 years old. According to the reports, one of them had not displayed any symptoms, while the other was having trouble breathing. Here is an update on the COVID-19 JN.1 variant in Karnataka.
COVID-19 JN.1 Variant: 2 People Died In Karnataka
The Sars CoV-2 virus also claimed the life of a 64-year-old man from Chamarajpet, Bengaluru, a few days ago, Karnataka Health Minister Dinesh Gundu Rao stated. He went on to say that it’s unclear if the new subvariant is what killed him. According to the Minister, the deceased had several comorbid conditions, including a tuberculosis infection, hypertension, lung illness, bronchial asthma, pneumonia, and heart failure.
After conducting 808 tests on Wednesday, 407 of which were RT PCR tests and 401 of which were Rapid Antigen Tests (RAT), Karnataka recorded 20 new cases. The positive rate for the state was 2.47 per cent.
In the state, there were 92 current cases, the majority of which were minor. Twenty individuals were admitted to the hospital. Of these, 13 were in regular wards and seven were getting care in the intensive care unit. Of the 72 victims, 72 were isolated in their homes. On Wednesday, five patients made a full recovery and were released, according to a report from the state health department.
Karnataka had 40.89 lakh cases of COVID-19 overall, with a 10% case fatality rate. The health administration of the state recently recommended wearing face masks in public for the elderly (those over 60), people with comorbidities (particularly liver, heart, and renal conditions), expectant mothers, and nursing moms.
Also Read: COVID-19 Cases Surge In Some Asian Countries; Face Masks & Scanners Return At Airports
5,000 Testings Per Day
In response to the surge in illnesses, the state administration also decided to step up testing, announcing that in the following three days, officials would do 5,000 tests every day.
The New Variant In India:
This variety has now been detected in the US, China, and India. It is a descendant of Pirola. Around the world, the discovery of this unusual strain has generated curiosity and concern.
The only mutation in the spike protein that separates the JN.1 variant from Pirola or BA. 2.86 is a single one. Although its high transmissibility and mild symptoms are similar to those of earlier Omicron strains, there are some symptoms that people should be aware of since they could not be as mild as those of prior Omicron variants.
Experts report that fever, runny nose, sore throat, headache, and, in some cases, mild gastrointestinal issues are the earliest signs of the JN.1 COVID strain. Some patients may also have trouble breathing.
Also Read: Maharashtra: 41-YO Man Was Tested Positive For COVID-19 JN.1 Variant In Sindhudurg District
It is crucial to remember that, as of right now, there is no proof that this variation is more deadly or more severe than other variants.
Cover Image Courtesy: Flickr/ UN Women Asia and the Pacific
For more such snackable content, interesting discoveries and latest updates on food, travel and experiences in your city, download the Curly Tales App. Download HERE.
Good news! We are on WhatsApp! Subscribe to Curly Tales WhatsApp Channel to stay up-to-date with exclusive content and BTS. Join HERE.